ALR Technologies, Inc. – Drugs don’t work in patients who don’t take them.
— C. Everett Koop, M.D.
ALRT — ALR Technologies, Inc.
Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)
ALR Technologies Supports Healthcare Industry with Cost Effective System and Generates Ongoing Revenue
ALR Technologies is working with PageMinder, Inc., a health compliance services company based in Nevada, Missouri. Page Minder has placed an order for the ALRT500 health management system. The ALRT system will provide continuous reminders and monitoring of patient medications and treatments. Each Missouri Medicaid asthma patient that will be utilizing the system will have it programmed to meet their individual specific needs. The basis for this expense is the fact that in the long run medication compliance is cost effective. It is less expensive than non-compliance and the emergency room visit of health disaster which accompanies medication non-compliance
Medication non-compliance as supported the new industry is arising in healthcare known as the Disease Management Industry. The Disease Management Industry developed into multi-billion dollar business. Sales of devices and digital services for home monitoring are projected to grow from $461 million in 2005 to over $2.5 billion in 2010, says Harry Wang, an analyst with research and consulting group Parks Associates in Dallas.
The disease management concept gained momentum through the last half of the 1990s when health care premiums started rising. This industry is focused on health management systems. ALRT is one of the first to arrive and stake out their territory. The concept was first embraced by some health insurance companies then by self-funded employers, by some state Medicaid agencies and, now, the federal government.
Some of Medicare’s most difficult and expensive patients are the growing number of elderly Americans suffering from diabetes or congestive heart problems or both. Diabetes and congestive heart failure because they consume a disproportionate share of Medicare dollars. Of Medicare’s more than 40 million beneficiaries, about 14 percent have congestive heart problems and 18 percent have diabetes. Yet they account for 43 percent and 32 percent of Medicare spending, respectively.
Reaping the most money for the federal government for medicare is the key to success and success lies where savings are realized by disease management. That’s where ALR Technologies products come in. They are cost efficient in terms of reducing the overall expense associated with treatment. Their revenue stream is found less in their products than the ongoing services provided. They are similar to the cell phone industry in that fashion.
PageMinder, Inc., a health compliance services company based in Nevada, Missouri, has placed an order for the ALRT500 health management system. The ALRT system provides continuous reminders and monitoring of patient medications and treatments. Each Missouri Medicaid asthma patient that will be utilizing the system will have it programmed to meet their individual specific needs.
ALR Techologies is providing the right resources at the right time and they are on the cutting edge of a new industry in a business that has a re-occuring revenue stream with the services provided in conjunction with their products.
Stay tuned for more on this company as we look at the recurring and regenerative revenue stream provided by this system.
Source: ALR Technologies and Wall Street Journal
Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com
Sidney Chan, CEO
ALRT — ALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254
SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p
Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.
Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.